MyFinsight
Home
Blog
About
Contact
Inventory
$1,001,112K
Cash and cash
equivalents
$464,450K
Accounts receivable, net
$394,817K
Short-term investments
$188,739K
Other current assets
$187,973K
Manufacturing-related deposits and
prepaids
$72,785K
Total current assets
$2,309,876K
Property and equipment,
net
$336,241K
Non-current inventory
$174,865K
Other non-current
assets
$151,957K
Right of use assets
$124,059K
Non-current investments
$81,936K
Total assets
$3,178,934K
Total liabilities and
stockholders equity
$3,178,934K
Total liabilities
$1,673,832K
Total stockholders
equity
$1,505,102K
Accumulated deficit
-$4,546,025K
Treasury stock, at cost,
655,642 and 650,876...
$25,263K
Accumulated other
comprehensive income (loss),...
-$121K
Long-term debt
$838,162K
Total current
liabilities
$499,164K
Lease liabilities,
net of current...
$198,505K
Deferred revenue, net of
current portion
$136,354K
Other non-current
liabilities
$1,647K
Additional paid-in capital
$6,076,500K
Common stock, 0.0001
par value,...
$11K
Accrued expenses
$302,372K
Deferred revenue,
current portion
$116,037K
Accounts payable
$70,376K
Other current
liabilities
$10,379K
Back
Back
Balance Sheet
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
source: myfinsight.com
Sarepta Therapeutics, Inc. (SRPT)